The influence of pharmacological pretreatment on efficacy of HI-6 oxime in combination with benactyzine in soman poisoning in rats

Human & Experimental Toxicology

Volumn 15, Issue 5, 1996, Pages 383-388

  Kassa, Jiří ^a   Bajgar, Jiří ^a  

^a DEPARTMENT OF TOXICOLOGY   (Czech Republic)

Author keywords

acetylcholinesterase; benactyzine; corticosterone; HI 6; PANPAL pretreatment; soman; tyrosine aminotransferase

Indexed keywords

1 (4 CARBAMOYLPYRIDINIO) 1' (2 HYDROXYIMINOMETHYLPYRIDINIO)DIMETHYL ETHER; BENACTYZINE; CHOLINESTERASE; CORTICOSTERONE; OXIME; PYRIDOSTIGMINE; SOMAN; TRIHEXYPHENIDYL; TYROSINE AMINOTRANSFERASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD; BRAIN; CHOLINERGIC ACTIVITY; CHOLINESTERASE INHIBITION; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; DIAPHRAGM; DRUG EFFICACY; ENZYME ACTIVITY; INTOXICATION; LIVER; MALE; NONHUMAN; PRIORITY JOURNAL; PROPHYLAXIS; RAT;

ANIMALS; ANTIDOTES; BENACTYZINE; BRAIN; CHOLINESTERASE INHIBITORS; CHOLINESTERASE REACTIVATORS; CHOLINESTERASES; CORTICOSTERONE; DIAPHRAGM; DRUG THERAPY, COMBINATION; LIVER; MALE; MUSCARINIC ANTAGONISTS; OBIDOXIME CHLORIDE; POISONING; PYRIDINIUM COMPOUNDS; PYRIDOSTIGMINE BROMIDE; RATS; RATS, WISTAR; SOMAN; TRIHEXYPHENIDYL; TYROSINE TRANSAMINASE;

ANIMALIA;

EID: 0029972017     PISSN: 09603271     EISSN: None     Source Type: Journal    
DOI: 10.1177/096032719601500503     Document Type: Article

References (26)

1. Taylor P. Anticholinesterase agents. In: Gilman AG, Goodman LS, Rall TW and Murod F (eds.), Goodman and Gilman's The Pharmacological Basis of Therapeutics. 7th edn. New York: Macmillan Press, 1985.
2. Marrs TC Organophosphate poisoning. Pharmacology and Therapy 1993; 58: 51-66.
3. Dawson RM Review of oximes available for treatment of nerve agent poisoning. Journal of Applied Toxicology 1994; 14: 317-331.
4. Bajgar J. Intoxication with organophosphorus inhibitors of cholinesterases (in Czech). First edn. Prague: Avicenum, 1985.
5. Rousseaux CG, Dua AK Pharmacology of HI-6, a series oxime. Canadian Journal of Physiology and Pharmacology 1989; 67: 1183-1189.
6. Bošković B., Kovacević V., Jovanović D. 2-PAMCl, HI-6 and HGG-12 in soman and tabun poisoning. Fundamental and Applied Toxicology 1984; 4: S106-S115.
7. Shih T-M., Whalley Che, Valdes JJ A comparison of cholinergic effects of HI-6 and pralidoxime-2-chloride (2-PAM) in soman poisoning. Toxicology Letters 1991; 55: 131-147.
8. Shih T-M. Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue cholinesterase activity in rats. Archives of Toxicology 1993; 67: 637-646.
9. Koplovitz I., Stewart JR A comparison of the efficacy of HI-6 and 2-PAM against soman, tabun, sarin and VX in the rabbit. Toxicology Letters 1994; 70: 269-279.
10. Kassa J. Comparison of efficacy of two oximes (HI-6 and obidoxime) in soman poisoning in rats. Toxicology 1995; 101: 167-174.
11. Bajgar J., Fusek J., Vachek J. Theoretical approaches and practical possibilities of medical prophylaxis against nerve agent poisoning. CATE 95, May 2-6 1995; Brno, Czech Republic.
12. Bajgar J., Fusek J., Vachek J. Prolonged effects of prophylactic mixtures against nerve agent poisoning. CBW Medical Treatment Symposium, December 5-8 1994, Spiez, Switzerland.
13. Brodbeck U., Gentinetta R. Inhibition of blood acetylcholinesterase after single and repeated doses of pyridostigmine. CBW Medical Treatment Symposium, December 5-8 1994, Spiez, Switzerland.
14. Bajgar J., Fusek J., Vachek J. Treatment and prophylaxis against nerve agent poisoning. ASA Newsletter 1994; 94-4: 10-11.
15. Vachek J., Kassa J., Fusek J., Bajgar J. Present possibilities of treatment of organophosphate poisoning (in Czech). Sborník vēdeckjych prací VLA JEP Hradec Králové 1993; 116: 67-95.
16. Owayoso JO, Okonmah AD, Soliman Kfa, Walker CA Circadian acetylcholinesterase activity of specific rat brain areas. Journal Interdisciplinal Cycle Research 1980; 11: 251-256.
17. Schreiber V. Stress (in Czech). First edn. Prague: Avicenum, 1985.
18. Ellman GL, Courtney DK, Andres Vjr, Featherstone RM A new and rapid colorimetric determination of acetylcholinesterase activity. Biochemistry and Pharmacology 1961; 7: 88-95.
19. Ježová-Repčeková D., Vigaš M., Kulifajová A. Effect of phentolamine and clonidine on pituitary-adrenocortical axis during stress in conscious rats. Endocrinologia experimentalis 1978; 12: 3-8.
20. Diamondstone TI Assay of tyrosine transaminase activity by conversion of p-hydroxyphenylpyruvate to p-hydroxybenzaldehyde. Analytical Biochemistry 1966; 16: 395-401.
21. Wenger B., Quigley MD, Kokla MA Seven-day pyridostigmine administration and thermoregulation during rest and exercise in dry heat. Aviation, Space and Environmental Medicine 1993; 64: 905-911.
22. Gouge SF, Daniels DJ, Smith CE Exacerbation of asthma after pyridostigmine during Operation Desert Storm. Military Medicine 1994; 159: 108-111.
23. Leadbeater L., Inns RH, Rylands JM Treatment of poisoning by soman. Fundamental and Applied Toxicology 1985; 5: S225-S231.
24. Walday P., Aas P., Haider T., Fonnum F. Effect of pyridostigmine pretreatment, HI-6 and toxogonin treatment on rat tracheal smooth muscle response to cholinergic stimulation after organophosphorus inhalation exposure. Archives of Toxicology 1993; 64: 212-219.
25. Koplovitz I., Harris LW, Anderson DR, Lennox WJ, Stewart, JR Reduction of pyridostigmine pretreatment of the efficacy of atropine and 2-PAM treatment of sarin and VX poisoning in rodents. Fundamental and Applied Toxicology 1992; 18: 102-106.
26. Worek F., Szinicz L. Effect of pyridostigmine pretreatment on circulation and respiration in nerve agent poisoned guinea-pigs treated with atropine and various oximes. Fifth International Symposium on Protection against Chemical and Biological Warfare Agents, June 11-16. 1995; Stockholm, Sweden.